Source: MassDevice

Precision Biopsy: Precision Biopsy asks FDA to OK new ClariCore trial

Precision Biopsy said today it submitted an application to the FDA seeking a go-ahead to expand the trial of its ClariCore prostate biopsy system into a new Transrectal Ultrasound and MR/Fusion arm. The ClariCore system is designed for the spectral analysis of tissue samples during biopsies to "rapidly classify" tissue as normal or suspicious using an [...]The post Precision Biopsy asks FDA to OK new ClariCore trial appeared first on MassDevice.

Read full article »

Top Competitors or Alternatives

Looks like nobody has added any competitors for Precision Biopsy yet.

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Amir Tehrani's photo - CEO of Precision Biopsy

CEO

Amir Tehrani

CEO Approval Rating

68/100

Precision Biopsy develops optical biopsy devices to improve the accuracy and reliability of prostate biopsies and the diagnosis of prostate cancer. Read more